[go: up one dir, main page]

Kraft-Sheleg et al., 2016 - Google Patents

Localized LoxL3-dependent fibronectin oxidation regulates myofiber stretch and integrin-mediated adhesion

Kraft-Sheleg et al., 2016

View HTML @Full View
Document ID
8697537187013984672
Author
Kraft-Sheleg O
Zaffryar-Eilot S
Genin O
Yaseen W
Soueid-Baumgarten S
Kessler O
Smolkin T
Akiri G
Neufeld G
Cinnamon Y
Hasson P
Publication year
Publication venue
Developmental cell

External Links

Snippet

For muscles to function, myofibers have to stretch and anchor at the myotendinous junction (MTJ), a region rich in extracellular matrix (ECM). Integrin signaling is required for MTJ formation, and mutations affecting the cascade lead to muscular dystrophies in mice and …
Continue reading at www.cell.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans

Similar Documents

Publication Publication Date Title
Kraft-Sheleg et al. Localized LoxL3-dependent fibronectin oxidation regulates myofiber stretch and integrin-mediated adhesion
Eliazer et al. Wnt4 from the niche controls the mechano-properties and quiescent state of muscle stem cells
Eigler et al. ERK1/2 inhibition promotes robust myotube growth via CaMKII activation resulting in myoblast-to-myotube fusion
Keipert et al. Long-term cold adaptation does not require FGF21 or UCP1
Lv et al. The lncRNA Plscr4 controls cardiac hypertrophy by regulating miR-214
Kim et al. Fine-tuning of Drp1/Fis1 availability by AKAP121/Siah2 regulates mitochondrial adaptation to hypoxia
Zaïmia et al. GLP-1 and GIP receptors signal through distinct β-arrestin 2-dependent pathways to regulate pancreatic β cell function
Tharp et al. Actomyosin-mediated tension orchestrates uncoupled respiration in adipose tissues
Liu et al. LncRNA NONRATT021972 siRNA regulates neuropathic pain behaviors in type 2 diabetic rats through the P2X7 receptor in dorsal root ganglia
Ehlers et al. NFATc1 controls skeletal muscle fiber type and is a negative regulator of MyoD activity
Yu et al. WLS retrograde transport to the endoplasmic reticulum during Wnt secretion
Zhang et al. The demethylase activity of FTO (fat mass and obesity associated protein) is required for preadipocyte differentiation
Zhang et al. Hypoxia-inducible factor 3 is an oxygen-dependent transcription activator and regulates a distinct transcriptional response to hypoxia
Zhou et al. The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression
Diao et al. Pax3/7BP is a Pax7-and Pax3-binding protein that regulates the proliferation of muscle precursor cells by an epigenetic mechanism
Li et al. Follistatin-like 1 suppresses sensory afferent transmission by activating Na+, K+-ATPase
Kalashnikova et al. SynDIG1: an activity-regulated, AMPA-receptor-interacting transmembrane protein that regulates excitatory synapse development
Pedrotti et al. The RNA-binding protein Rbfox1 regulates splicing required for skeletal muscle structure and function
Xu et al. Sox10 escalates vascular inflammation by mediating vascular smooth muscle cell transdifferentiation and pyroptosis in neointimal hyperplasia
Matilainen et al. Insulin/IGF-1 signaling regulates proteasome activity through the deubiquitinating enzyme UBH-4
You et al. Drosophila perlecan regulates intestinal stem cell activity via cell-matrix attachment
Kluth et al. Decreased expression of cilia genes in pancreatic islets as a risk factor for type 2 diabetes in mice and humans
Laprise et al. Epithelial polarity proteins regulate Drosophila tracheal tube size in parallel to the luminal matrix pathway
Rozen et al. DYRK1A kinase positively regulates angiogenic responses in endothelial cells
Jakkaraju et al. TIPs are tension-responsive proteins involved in myogenic versus adipogenic differentiation